BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30133622)

  • 1. Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis.
    Matos ECO; Andriolo RB; Rodrigues YC; Lima PDL; Carneiro ICDRS; Lima KVB
    Rev Soc Bras Med Trop; 2018; 51(4):415-420. PubMed ID: 30133622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for acquisition of multidrug-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
    Nouér SA; Nucci M; de-Oliveira MP; Pellegrino FL; Moreira BM
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3663-7. PubMed ID: 16127037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options.
    Obritsch MD; Fish DN; MacLaren R; Jung R
    Pharmacotherapy; 2005 Oct; 25(10):1353-64. PubMed ID: 16185180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study.
    Peng Y; Bi J; Shi J; Li Y; Ye X; Chen X; Yao Z
    Am J Infect Control; 2014 Dec; 42(12):1308-11. PubMed ID: 25444305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
    Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
    J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the multifactor dimensionality reduction method in evaluation of the roles of multiple genes/enzymes in multidrug-resistant acquisition in Pseudomonas aeruginosa strains.
    Yao Z; Peng Y; Bi J; Xie C; Chen X; Li Y; Ye X; Zhou J
    Epidemiol Infect; 2016 Mar; 144(4):856-63. PubMed ID: 26234343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of metallo β-lactamase producing multidrug resistant Pseudomonas aeruginosa from various clinical samples.
    Ramakrishnan K; Rajagopalan S; Nair S; Kenchappa P; Chandrakesan SD
    Indian J Pathol Microbiol; 2014; 57(4):579-82. PubMed ID: 25308010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-beta-lactamase-mediated multidrug resistance: a prospective observational study.
    Zavascki AP; Barth AL; Fernandes JF; Moro AL; Gonçalves AL; Goldani LZ
    Crit Care; 2006; 10(4):R114. PubMed ID: 16882337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
    Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
    J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
    Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
    Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcomes of multidrug resistant pseudomonas aeruginosa infection and the relationship with type III secretion system in patients with diabetic foot.
    Zhang J; Chu Y; Wang P; Ji X; Li X; Wang C; Peng Y
    Int J Low Extrem Wounds; 2014 Sep; 13(3):205-10. PubMed ID: 25106442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
    Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
    J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome.
    Joo EJ; Kang CI; Ha YE; Kang SJ; Park SY; Chung DR; Peck KR; Lee NY; Song JH
    Microb Drug Resist; 2011 Jun; 17(2):305-12. PubMed ID: 21381966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance.
    Micek ST; Wunderink RG; Kollef MH; Chen C; Rello J; Chastre J; Antonelli M; Welte T; Clair B; Ostermann H; Calbo E; Torres A; Menichetti F; Schramm GE; Menon V
    Crit Care; 2015 May; 19(1):219. PubMed ID: 25944081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of virulence factor pyocyanin production in multidrug-resistant Pseudomonas aeruginosa.
    Fuse K; Fujimura S; Kikuchi T; Gomi K; Iida Y; Nukiwa T; Watanabe A
    J Infect Chemother; 2013 Feb; 19(1):82-8. PubMed ID: 22865331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.
    Gailiene G; Pavilonis A; Kareiviene V
    Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.
    Mammina C; Di Carlo P; Cipolla D; Casuccio A; Tantillo M; Plano MR; Mazzola A; Corsello G
    Acta Pharmacol Sin; 2008 Dec; 29(12):1486-92. PubMed ID: 19026168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients.
    Varaiya A; Kulkarni N; Kulkarni M; Bhalekar P; Dogra J
    Indian J Med Res; 2008 Apr; 127(4):398-402. PubMed ID: 18577797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of infections caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa in the Calgary Health Region.
    Parkins MD; Pitout JDD; Church DL; Conly JM; Laupland KB
    Clin Microbiol Infect; 2007 Feb; 13(2):199-202. PubMed ID: 17328734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.